IFNG and hemophagocytic syndrome: Absence of hepatic IFN-γ response results in amelioration of hepatic dysfunction, endotheliitis, ECM disruption as well as recruitment and activation of immune main mediators of FHL hepatitis and suggest IFN-γ blockade may be viable hepatoprotective strategy in FHL and other CSS.